---
title: "Triflupromazine - Psychotic Disorder - 4"
sidebar: mydoc_sidebar
permalink: db00508-mesh-d011618-4.html
toc: false 
---


Path ID: `DB00508_MESH_D011618_4`
{% include image.html url="images/db00508-mesh-d011618-4.png" file="db00508-mesh-d011618-4.png" alt="db00508-mesh-d011618-4" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014273 | triflupromazine | Drug |
| UniProt:P08172 | Muscarinic acetylcholine receptor M2 | Protein |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| HP:0008760 | violent behavior | PhenotypicFeature |
| MESH:D011618 | psychotic disorders | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Triflupromazine | DECREASES ACTIVITY OF | Muscarinic Acetylcholine Receptor M2 |
| Muscarinic Acetylcholine Receptor M2 | LOCATED IN | Central Nervous System |
| Central Nervous System | PREVENTS | Violent Behavior |
| Violent Behavior | CORRELATED WITH | Psychotic Disorders |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00508#mechanismofaction](https://go.drugbank.com/drugs/DB00508#mechanismofaction)
